رب اجعل هذا بلدا آمنا وارزق أهله من الثمرات من امن منهم بالله و اليوم الآخر.

Slides:



Advertisements
Similar presentations
Fever in the ICU Christopher Kia.
Advertisements

Prevention of Ventilator Associated Pneumonia
SEPTICAEMIA Dr. Urvesh V. Shah Associate Professor Editor in Chief, Dept. of Microbiology, GCSMC Journal Of GCS Medical College Medical Sciences.
ARE CAP AND HCAP TWO SEPARATE ENTITIES? Francesco Blasi Department Pathophysiology and Transplantation, University of Milan, Italy.
Controversies in Critical Care David A. Schulman, MD, MPH Chief, Pulmonary and Critical Care Medicine, Emory University Hospital Training Program Director,
Community Acquired Pneumonia Guidelines 2011 Top 11 Recommendations Michael H. Kim.
Copyright Wigfull 2013 The Sepsis Timebomb James Wigfull Critical Care and Anaesthesia Sheffield Teaching Hospitals.
SEPSIS KILLS program Adult Inpatients
Procalcitonin Over the past two decades, the body of literature on the clinical usefulness of procalcitonin (PCT) in adults has grown rapidly. Although.
Pulmonary Tuberculosis and Lung Cancer. Diagnosis of Primary Tumor  Sputum Cytology  Flexible Bronchoscopy and Biopsy  TTNA transthoracic needle aspiration.
BETHLEHEM UNIVERSITY Second Neonatal Gathering Fall 2007.
Role of MRSA Swabs for De-escalation of Antibiotics in HCAP
Correlation of Leukocyte Count with Clinical Outcomes in Hospitalized Patients with Community-Acquired Pneumonia: Results from Rapid Empiric Treatment.
Early Goal Therapy in Severe Sepsis & Septic Shock
Systemic inflammatory response syndrome score at admission independently predicts mortality and length of stay in trauma patients. by R2 黃信豪.
CHAPTER 7 PRINCIPLES OF DISEASE © Andy Crump / Science Photo Library.
procalcitonin: Advancing Decision Making in sepsis
G aps, challenges and opportunities Theo Verheij University Medical Center Utrecht Lower Respiratory Tract Infections in Primary Care.
Serum Procalcitonin Level and Other Biological Markers to Distinguish Between Bacterial and Aseptic Meningitis in Children A European Multicenter Case.
SEPSIS Early recognition and management. Aims of the talk Understand the definition of sepsis and severe sepsis Understand the clinical significance of.
C-Reactive Protein: a Prognosis Factor for Septic Patients Systematic Review and Meta-analysis Introduction to Medicine – 1 st Semester Class 4, First.
Clinical Discussant: David B. Pearse, M.D.
The Nature of Disease.
Infections in acute exacerbation of COPD: are the agents the same ?
Julio A. Ramirez, MD, FACP Professor of Medicine Chief, Infectious Diseases University of Louisville Chief, Infectious Diseases Veterans Affairs Medical.
The Importance of Viral Etiology in Hospitalized Patients with Community Acquired Pneumonia in Jefferson County Martin Gnoni MD, Swetha Kadali, MD, Jorge.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 83 Basic Principles of Antimicrobial Therapy.
1 Developed by Consensus III Medical Expert Group : Gert Höffken, Universitat Dresden, Dresden, Germany George Karam, Louisiana State University Medical.
Procalcitonin-Guided Antibiotic Therapy
سورة البقرة ( ۳۲ ). Influenza is a serious respiratory illness which can be debilitating and causes complications that lead to hospitalization and.
Serum procalcitonin and C-reactive protein in children with community- acquired pneumonia K.Gogvadze, I.Guramishvili, I.Chkhaidze, K.Nemsadze, T.Maglakelidze.
Bacteremia and CRBSI as Labeled BSI Indications: A Regulatory History Alfred Sorbello, DO Medical Officer CDER/Division of Anti-Infective Drug Products.
Improving Patient Outcomes GLYCEMIC CONTROL IN PERI-OPERATIVE PATIENTS UTILIZING INSULIN INFUSION PROTOCOLS.
Value of rapid antigen detection tests (RADTs) for diagnosis of invasive group A Streptococci (GAS) 3-centre, retrospective study: N=192 miscellaneous.
Procalcitonin. Objectives Review current data on procalcitonin Review its use at UCI MC.
Using procalcitonin to care for hospitalized patients Hospitalist Best Practice J Rush Pierce Jr, MD, MPH Division of Hospital Medicine July 22, 2015.
Role of procalcitonin (PCT) in guiding antibiotic therapy Descriptive review of RCTs using PCT to guide antibiotic therapy –2 RCTs in outpatient primary.
Clare Dikken Macmillan Senior Chemotherapy Nurse Sussex Cancer Network
Diagnostic Criteria: Severe Community-Acquired Pneumonia Antonio Anzueto The University of Texas Health Science Center at San Antonio, Texas.
Procalcitonin-Guided Duration of Antimicrobial Therapy in Healthcare-Associated Pneumonia  PCT-guided group with decreased duration of antimicrobial therapy.
Pneumonia Egan’s Chapter 22. Mosby items and derived items © 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 2 Introduction Infection involving the.
Is the VIDAS B. R. A. H. M. S PCT assay able to detect a bacterial throat infection? Mr Ajith P George MBChB, MRCS, DO-HNS ENT SpR.
Mini BAL v/s Bronchoscopic BAL PROF. PRADYUT WAGHRAY MD (CHEST), DTCD, FCCP (USA),D.SC(PULM. MEDICINE) HEAD OF DEPT. OF PULMONARY MEDICINE S.V.S MEDICAL.
Haemofiltration for sepsis: burial or resurrection?
New Concepts in Microbiology of Exacerbations of COPD Sanjay Sethi MD Professor Pulmonary, Critical Care and Sleep Medicine University at Buffalo, SUNY.
United States Statistics on Sepsis
MICROBIOLOGICAL EPIDEMIOLOGY OF RESPIRATORY SPECIMENS IN ICU PATIENTS Dr Farooq Cheema, Dr Waseem Tariq, Dr Raja Ishtiaq, Dr Tabassum Qureshi, Dr Vincent.
Procalcitonin 정량검사의 평가
폐렴으로 오인할 수 있는 폐렴 외 질환 호흡기 내과 R3 최 문 찬.
Comparison of clinical failure between procalcitonin algorithm-compliant versus procalcitonin algorithm-non-compliant antibiotic prescribing in patients.
Depart. Of Pulmonology and Critical Care Medicine R4 백승숙.
Antibiotics in Addition to Systemic Corticosteroids for Acute Exacerbations of Chronic Obstructive Pulmonary Disease Johannes M.A. Daniels; Dominic snijders;
Utility of Procalcitonin concentration in the evaluation of patients with malignant diseases and elevated c- reactive protein plasma concentration Silke.
Community Acquired Pneumonia. Definitions Community acquired pneumonia (CAP) – Infection of the lung parenchyma in a person who is not hospitalized or.
Role of Procalcitonin in Managing Adult Patients With Respiratory Tract Infections Philipp Schuetz, MD, MPH; Devendra N. Amin, MD, FCCP; and Jeffrey L.
Time for first antibiotic dose is not predictive for the early clinical failure of moderate–severe community-acquired pneumonia Eur J Clin Microbial Infect.
Etiology of Illness in Patients with Severe Sepsis Admitted to the Hospital from the Emergency Department Alan C. Heffner,1,3 James M. Horton,2 Michael.
Department of Pulmonology 백승숙. Community-acquired pneumonia (CAP) –The most common cause of severe sepsis and the leading cause of death from infection.
HAP and VAP Guidelines Update
CALS Instructor Update July 14, 2016
A New Anti-inflammatory Therapy For COPD
Biomarker-Driven Management of Sepsis and Antibiotics Evidence and Perspectives.
Intra-Abdominal Candidiasis, Candida peritonitis
PCP: management of co-infection
Capillary Albumin Transudation Rate and Outcome in Critically Ill Subjects Stephanie Yan, MD, Colin Doyle, MD, David Inouye, MD, Scott Harvey, MD, Michael.
PCP: management of co-infection
Markers of acute inflammation in assessing and managing lower respiratory tract infections: focus on procalcitonin  B. Müller, C. Prat  Clinical Microbiology.
Ordering Sputum Cultures in Community Acquired Pneumonia
Should I still screen for possible sepsis with SIRS criteria?
Community Acquired Pneumonia
Presentation transcript:

رب اجعل هذا بلدا آمنا وارزق أهله من الثمرات من امن منهم بالله و اليوم الآخر

Clinical Implication of Serum Procalcitonin in Sepsis and pneumonia Lecturer of chest diseases, Assuit faculty of medicine

 The most common cause of death in intensive care units  Mortality rate up to 50% depending on severity.  Early diagnosis and intervention markedly reduce the mortality

I NFECTION S OURCE IN S EVERE S EPSIS Angus DC et al. Crit Care Med. 2001; 29:1303

20 to 50% of them will ultimately die The major infection-related cause of death in developed countries 10 to 20% admitted to the intensive care unit

Fight as much as you can  Early diagnosis and intervention  Differentiate between infectious and non infectious case of systemic inflammation

Early diagnosis is essential to :  Administer the correct treatment  Avoid unnecessary antibiotic use  Reducing the morbidity, mortality  And decrease care-related costs. Cantürk et al., Turk J Med Sci 2008; 38 (2):

Delays treatment Increases hospital length-of-stay Increases costs Increased mortality Delayed diagnosis

Delayed intervention can be fatal Sebat CCM 2007; 35: 2568

It is very important to differentiate between infectious and non infectious case of systemic inflammation

Inability to differentiate between infectious and non infectious causes Unplanned use of antibiotics Antibiotic resistance

Chen et al, 2008 Chinese Medical Journal, 2008,Chinese Medical Journal, 2008, 70% are infectious in origin. 20–30% related to bacteria detected by sputum culture viruses are detected in >50% of exacerbations Bacteria are isolated from the respiratory tract of only 50% of patients Dauben et al., BMC Infect Dis. 2008; 8: 145.

 Antibiotics were found to have been prescribed in 85% of patients admitted for AE-COPD to 360 hospitals throughout the USA  Drug costs accounted for more than 70% of the total costs AE- COPD Chen et al, 2008 Chinese Medical Journal, 2008,Chinese Medical Journal, 2008,

Antibiotic sensitivity for AECOPD in Upper Egypt Agamy et al., Egyp.J. Ch.dises. And tub. 2011

Antibiotic sensitivity for CAP and HAP in Upper Egypt Agamy et al., Egyp.J. Ch.dises. And tub. 2011

Acute phase reactants Capable of demonstrating the inflammation differentiate between bacterial and nonbacterial inflammation

CRP and leukocyte count do not have sufficient specificity in differentiating between bacterial infections, non-infectious systemic inflammations or viral infections. Cantürk et al., Turk J Med Sci 2008; 38 (2):

 Because most microbiological test results are not available for 24 h, a sensitive and specific marker of systemic infection would be useful. Hausfater et al, Clinical Infectious Diseases Volume 34, Issue 7Pp Clinical Infectious DiseasesVolume 34, Issue 7 Reimer et al. Clinical Microbiol Rev 1997; 10:

We are in need for a simple and rapid laboratory method to:  Guide antibiotic use  Predict the prognosis  Predict mortality  Differentiate between infectious and non infectious causes of systemic inflammation

(PCT) levels appears to be useful in order to minimize this problem. The sensitivity and specificity of PCT in bacterial infections were found to be 92.6% and 97.5% Cantürk et al., Turk J Med Sci 2008; 38 (2):

Bacterial toxins and cytokines Invasion by pathogenic bacteria Stimulate PCT production in all paraynchymal cells Adapted from Christ-Crain et al. 2005

22

23 VALUES OF PROCALCITONIN IN INFECTION

24 1- PCT LEVEL INCREASE = INCREASED SIGNIFICANCE OF BACTERIAL INFECTION

25 2- Differentiates between bacterial contamination and real bacterial infection  PCT may help discriminate blood stream infections from blood culture contamination due to coagulase-negative staphylococci Schuetz P. et al., Infection 2007;35 (5): 352-5

26 3- Predicts bacteremia Muller et al. CHEST July 2010 PCT measurement demonstrated the potential to reduce the number of blood cultures

27 PneumoniaSepsis 4- PROCALCITONIN CORRELATES TO THE SEVERITY OF THE INFECTION Harbarth S et al. Am J Respir Crit Care Med 2001, 164: Meisner M et al., Critical Care 1999, 3(1): Krüger S. et al., Eur Respir J 2008; 31: 349–355

28 Huang, et.al., Annals of Emergency Medicine, Vol 51, March 2008 Low PCT levels identify patients presenting in the ED that have a low risk for mortality 5- Evaluates the prognosis PCT

29 Decreasing PCT levels indicate effective treatment of the underlying infection Persistently elevated PCT levels indicate a possible treatment failure 6- Evaluates patient response to antibiotics Stueber, F. University of Bonn, Lecture at ISICEM, Brussels 2001

30 Nobre V. et alAM Resp Crit Care Med 2008: 177: Effect of PCT-guided management in patients with sepsis on ICU length of stay PCT GUIDANCE IN ANTIBIOTIC USAGE E FFECTS ON LENGTH OF STAY

31 PCT levels do not increase in some of the disease entities that cause the FUO syndrome, e.g., Still's disease, systemic lupus erythematosus, and inflammatory bowel disease 7- Sort out the etiology of the fever in patients with the fever of unknown origin (FUO) syndrome

32  PCT levels are not affected by the patient's use of nonsteroidal anti- inflammatory agents or glucocorticoids PCT levels remain a valuable marker of the host inflammatory response even when nonsteroidal anti-inflammatory drugs and corticosteroids are used

33 Simon L. et al. Clin Infect Dis. 2004; 39: PCT levels accurately differentiate sepsis from noninfectious inflammation* PCT has been demonstrated to be the best marker for differentiating patients with sepsis from those with systemic inflammatory reaction not related to infectious cause D IAGNOSTIC ACCURACY OF PCT COMPARED TO OTHER BIOMARKERS USED IN SEPSIS

34 False negative results Low PCT levels in the presence of bacterial infection may occur: Early course of infection: Re-measure in 6-12hrs Subacute Endocarditis Localized infections

35  Cirrhosis  Pancreatitis  Mesenteric infarction (ischemic bowel)  Cardiogenic shock, and hypotension during surgery  Burns  Pulmonary edema and pulmonary aspiration False positive results

36  PCT is usefull to diffrentiate between bacterial and non bacterial infection  Differentiates between bacterial contamination and real bacterial infection  Predicts bacteremia

37  PCT level correlates with the severity of infection in sepsis and pneumonia  Evaluates the prognosis  Evaluates patient response to antibiotics  Sort out the etiology of the fever in patients with the fever of unknown origin (FUO) syndrome

38 Never ever forget to love those dearest to you